Pernille‐Julia Vig Hjarnaa

Author

Also Known As

P. V. HJARNAA, Pernille-Julia Hjarnaa, Pernille-Julia V. Hjarnaa, Pernille-Julia Vig Hjarnaa, Pernille‐Julia Vig Hjarnaa

Publications

260

Citations

H-Index

Concepts

All Affiliations

Pernille‐Julia Vig Hjarnaa is an author at Leo Pharma (Denmark) specializing in medicine, pharmacology, and radiation oncology.

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	244
2	Engineering	2	2	50
3	Biomedical Engineering	2	2	50
4	Natural Sciences	1	1	94
5	Biochemistry	1	1	94

Pernille‐Julia Vig Hjarnaa

Publications

244

Citations

H-Index

Page 1

	Year	Citations
Cyclic phosphinamides and phosphonamides, novel series of potent matrix metalloproteinase inhibitors with antitumour activity Morten Dahl Sørensen, Lars K. A. Blæhr, Mette Krogh Christensen, Bioorganic & Medicinal Chemistry Medicinal ChemistryNovel SeriesBiochemistryMedicineNatural Sciences	2003	94
Non-anti-coagulant heparin inhibits metastasis but not primary tumor growth. Michael Kragh, Lise Binderup, Pernille‐Julia Vig Hjarnaa, PubMed Tumor BiologySpontaneous MetastasisMedicinePharmacologyLower Molecular Weight	2005	55
Anticancer agent CHS 828 suppresses nuclear factor‐κB activity in cancer cells through downregulation of IKK activity L. S. Olsen, Pernille‐Julia Vig Hjarnaa, Scilla Latini, International Journal of Cancer ApoptosisImmunologyCell DeathCancer BiologyTumor Biology	2004	45
In vivo chamber angiogenesis assay: An optimized Matrigel plug assay for fast assessment of anti-angiogenic activity Michael Kragh, Pernille‐Julia Vig Hjarnaa, E. Bramm, International Journal of Oncology Tissue EngineeringEngineeringBiomedical EngineeringRegenerative MedicineAnti-angiogenic Activity	2003	39
The Rat Subcutaneous Air Sac Model: A Quantitative Assay of Antiangiogenesis in Induced Vessels Jens Lichtenberg, Pernille‐Julia Vig Hjarnaa, Paul E.G. Kristjansen, Pharmacology & Toxicology Tissue EngineeringEngineeringQuantitative AssayPathologyBiomedical Engineering	1999	11

Page 1